Joseph F. Lawler - Apr 21, 2022 Form 4 Insider Report for Anebulo Pharmaceuticals, Inc. (ANEB)

Role: Director, 10%+ Owner
Signature: /s/ Joseph F. Lawler
Stock symbol: ANEB
Transactions as of: Apr 21, 2022
Transactions value $: $0
Form type: 4
Date filed: 10/4/2022, 04:13 PM
Next filing: Jun 17, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ANEB	Common Stock						2M	Apr 21, 2022	Direct	F1
holding	ANEB	Common Stock						5M	Apr 21, 2022	By CAL GRAT 2022-1	F2
holding	ANEB	Common Stock						5M	Apr 21, 2022	By JFL GRAT 2022-1	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ANEB	Stock Option (right to buy)	Award	$0	+30.4K		$0.00	30.4K	Apr 21, 2022	Common Stock	30.4K	$6.00	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Excludes 10,000,000 shares previously owned directly by the reporting person which were contributed to grantor retained annuity trusts on September 26, 2022, and which shares are now reflected as owned indirectly in this Form 4.
F2	The reporting person is the sole trustee, and the reporting person and his spouse are the sole beneficiaries, of this grantor retained annuity trust.
F3	25% of the option vests on March 1, 2023. Thereafter, 1/48 of the option vests on a monthly basis over 36 months until the option becomes fully vested.